Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis

Cooper, N.J., Claxton, K. orcid.org/0000-0003-2002-4694, Chilcott, J., McCabe, C., Tappenden, P., O'Hagan, A. and Abrams, K. (2003) Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. BMJ. pp. 522-525. ISSN 1756-1833

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2003 BMJ Publishing Group Ltd
Institution: The University of York
Academic Units: The University of York > Economics and Related Studies (York)
Depositing User: Sherpa Assistant
Date Deposited: 20 Nov 2006
Last Modified: 16 Sep 2016 13:50
Published Version: http://dx.doi.org/10.1136/bmj.326.7388.522
Status: Published
Refereed: Yes

Download

Filename: claxtonk4.pdf

Description: claxtonk4.pdf

Share / Export